These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20954412)

  • 1. [Urgent percutaneous coronary intervention leads to a decrease in serum concentrations of soluble CD40 ligand].
    Ratković N; Romanović R; Jovelić A; Gligić B; Rafajlovski S; Vojvodić D; Obradović S
    Vojnosanit Pregl; 2010 Sep; 67(9):732-40. PubMed ID: 20954412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting.
    Yip HK; Wu CJ; Yang CH; Chang HW; Fang CY; Hung WC; Hang CL
    Circ J; 2005 Aug; 69(8):890-5. PubMed ID: 16041155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting.
    Yip HK; Chang LT; Sun CK; Yang CH; Hung WC; Cheng CI; Chua S; Yeh KH; Wu CJ; Fu M
    Am J Cardiol; 2006 Jan; 97(2):192-4. PubMed ID: 16442361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD40 ligand is an early initiator of inflammation after coronary intervention.
    Aggarwal A; Blum A; Schneider DJ; Sobel BE; Dauerman HL
    Coron Artery Dis; 2004 Dec; 15(8):471-5. PubMed ID: 15585987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis.
    Saleh N; Tornvall P
    Atherosclerosis; 2007 Dec; 195(2):374-8. PubMed ID: 17126343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between coronary plaque tissue composition assessed by virtual histology and blood levels of biomarkers for coronary artery disease.
    Ko YG; Le VC; Kim BH; Shin DH; Kim JS; Kim BK; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2012 May; 53(3):508-16. PubMed ID: 22476993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention--effects on soluble CD40 ligand concentrations.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Bosa-Ojeda F; Samimi-Fard S; Marrero-Rodriguez F; Kaski JC
    Atherosclerosis; 2009 Oct; 206(2):523-7. PubMed ID: 19380134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention triggers a systemic inflammatory response in patients treated for in-stent restenosis -- comparison with stable and unstable angina.
    Kozinski M; Krzewina-Kowalska A; Kubica J; Zbikowska-Gotz M; Dymek G; Piasecki R; Sukiennik A; Grzesk G; Bogdan M; Chojnicki M; Dziedziczko A; Sypniewska G
    Inflamm Res; 2005 May; 54(5):187-93. PubMed ID: 15953990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma inflammatory markers and platelet aggregation in patients with clopidogrel resistance after angioplasty.
    Ge H; Zhou Y; Liu X; Nie X; Wang Z; Guo Y; Chen W; Yang Q
    Angiology; 2012 Jan; 63(1):62-6. PubMed ID: 21602258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization.
    Gremmel T; Frelinger AL; Michelson AD
    PLoS One; 2015; 10(8):e0134599. PubMed ID: 26237513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Angeli F; Verdecchia P; Savonitto S; Cavallini S; Santucci A; Coiro S; Sclafani R; Riccini C; De Servi S; Cavallini C
    Clin Chem Lab Med; 2022 Jan; 60(1):118-126. PubMed ID: 34714987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.
    Pusuroglu H; Akgul O; Erturk M; Uyarel H; Bulut U; Akkaya E; Buturak A; Surgit O; Fuat A; Cetin M; Yldrm A
    Coron Artery Dis; 2014 Nov; 25(7):558-64. PubMed ID: 25004238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcoronary concentration gradient of sCD40L and hsCRP in patients with coronary heart disease.
    Wang Y; Li L; Tan HW; Yu GS; Ma ZY; Zhao YX; Zhang Y
    Clin Cardiol; 2007 Feb; 30(2):86-91. PubMed ID: 17326063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin.
    Anand SX; Kim MC; Kamran M; Sharma SK; Kini AS; Fareed J; Hoppensteadt DA; Carbon F; Cavusoglu E; Varon D; Viles-Gonzalez JF; Badimon JJ; Marmur JD
    Am J Cardiol; 2007 Aug; 100(3):417-24. PubMed ID: 17659921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention.
    Obradovic SD; Antovic JP; Antonijevic NM; Ratkovic NG; Vojvodic DV; Subota VS; Gligic BLj; Obradovic DV; Marinkovic JM; Wallen HN
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):283-9. PubMed ID: 19318922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Men with lower HDL cholesterol levels have significant increment of soluble CD40 ligand and high-sensitivity CRP levels following the cessation of long-term clopidogrel therapy.
    Obradovic S; Djukanovic N; Todorovic Z; Markovic I; Zamaklar-Trifunovic D; Protic D; Ostojic M
    J Atheroscler Thromb; 2015; 22(3):284-92. PubMed ID: 25273829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of clopidogrel loading before percutaneous coronary intervention in clopidogrel-naive patients with stable or unstable angina: a comparison of two strategies.
    Davlouros PA; Arseniou A; Hahalis G; Chiladakis J; Mazarakis A; Damelou A; Karakantza M; Paliogianni F; Karogiannis N; Alexopoulos D
    Am Heart J; 2009 Oct; 158(4):585-91. PubMed ID: 19781418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.